---  
layout: startup_page  
title: "ENYO Pharma"  
id: "enyopharma.com"  
permalink: "/enyopharmaenyopharma.com06122025/"  
website: "https://www.enyopharma.com/"  
funding_round: "Series C"  
funding_amount: "€32M"  
investors: "Vesalius Biocapital IV, OrbiMed, Morningside, AndEra, BPIFrance (InnoBio and Large Venture), Sofinnova Partners"  
about: "ENYO Pharma is a clinical-stage biotechnology company focused on developing FXR agonists for the treatment of severe kidney diseases. They are currently conducting a Phase 2 trial (ALPESTRIA-1) of Vonafexor in Alport syndrome patients, a rare genetic kidney disease. The company also plans to initiate two new clinical programs with the new funding."  
markets: "Biotech, Healthcare"  
hq: "Lyon, France"  
founded_year: "2014"  
linkedin: "https://www.linkedin.com/company/enyo-pharma"  
twitter: "https://twitter.com/enyopharma"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/enyo-pharma"  
pitchbook: "https://pitchbook.com/profiles/company/149476-60"  

date_display: "12-Jun-2025"  
date: "2025-06-12"

# SEO Optimization  
meta_title: "ENYO Pharma - Series C Funding (€32M)"  
meta_description: "ENYO Pharma, ENYO Pharma is a clinical-stage biotechnology company focused on developing FXR agonists for the treatment of severe kidney diseases. They are current..."  
meta_keywords: "ENYO Pharma, Biotech, Healthcare, Series C funding"  
canonical_url: "https://startup.projectstartups.com/enyopharmaenyopharma.com06122025/"  
---